(2S,3R,4S,5S,6R)-2-[(2R,3R,4R,5R)-5,6-Dihydroxy-2-(hydroxymethyl)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Metabolite details

Identifier

MLILOHBDBONATN-ITHDTYKHSA-N

InChI Key

MLILOHBDBONATN-ITHDTYKHSA-N

IUPAC name

Preferred name

(2S,3R,4S,5S,6R)-2-[(2R,3R,4R,5R)-5,6-Dihydroxy-2-(hydroxymethyl)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

INN name

—

Synonym

Gal(b1-3)[Glc(b1-4)]Glc

ChEBI

CHEBI:150042

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Unknown Metabolite Annotation in Mouse Aging using Ion Mobility Collision Cross-Section Atlas (AllCCS)

Observed in differential profiles

• 36_week_vs_104_week